MENU
RGLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Regulus Therapeutics (RGLS) Ownership - Who owns Regulus Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
4224 Campus Point Court
Phone
+1 858 202-6300
Employees
30
Web
https://www.regulusrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
106.11M
P/E Ratio
N/A
Total Cash
87.31M
Projected Growth
N/A
Total Debt
476K
Revenue
N/A
Risk (Beta)
1.21
Dividend Yield
N/A
Total Cash/Share
1.33
Total Debt/Equity
14.52
Revenue/Share
null USD as % of share price
Fundamentals
RGLS
Capitalization
106M
P/E Ratio
N/A
Risk (Beta)
1.21
Dividend Yield
N/A
Total Cash
87.3M
Total Cash/Share
1.33
Total Debt
476K
Total Debt/Equity
14.52
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
86.8M
P/B Ratio
1.22
Cash Flow
N/A
Earnings
-1.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
66K
Current Ratio
14.14
Current Revenue Per Employee
208333.33
Dividends Per Share - Security
N/A
EBITDA
-41.03M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-63.31
Shares Held By Institutions
163M
Shares Outstanding - Current
65.5M
Total Liabilities
6.96M
Total Volume MTD
N/A
Value
1
Gain YTD
26.563
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
4224 Campus Point Court
Phone
+1 858 202-6300
Employees
30
Web
https://www.regulusrx.com